-
Twist Bioscience Takes in Funding Round for DNA Synthesizer
Xconomy | Twist Bioscience yesterday announced a $26 million Series B funding round, as well as a $5 million DARPA contract, to continue development of a high-throughput DNA synthesis device.
May 28, 2014
-
Quantapore Receives $35m Investment Toward New Sequencer
San Francisco Business Times | An ex-Ion Torrent scientist has a $35 million investment to prove his new sequencer is faster and cheaper than anything else.
May 22, 2014
-
Advances in Genetic Engineering at the 2014 American Society for Microbiology Meeting
Bio-IT World | Presenters at the annual meeting of the American Society for Microbiology showed off new applications for the CRISPR system of gene editing, and projects that have re-coded bacterial genomes on a massive scale.
May 22, 2014
-
GenePeeks Launches Sperm Donor Matching Service
Bio-IT World News Brief | GenePeeks has opened its in silico nursery, formally launching the Matchright screening service for families who are planning to use a sperm donor to conceive.
May 22, 2014
-
N-of-One Signs Agreement with Mayo Clinic
Bio-IT World News Brief | Mayo Clinic and N-of-One, have signed an agreement under which N-of-One will provide Mayo Clinic with clinical interpretation information to aid in highly complex molecular diagnostics.
May 21, 2014
-
QIAGEN Adds HGMD and Other BIOBASE Offerings, Plans Ingenuity Clinical
Bio-IT World News Brief | QIAGEN is adding content from BIOBASE including HGMD, the human gene mutation database, to its bioinformatics offerings. HGMD and other BIOBASE solutions will provide the foundation for Ingenuity Clinical, QIAGEN's forthcoming clinical NGS decision-support solution.
May 21, 2014
-
A European Look at the Changing Landscape of Prenatal Testing
Bio-IT World | At the Prenatal Molecular Diagnostics Europe conference last week in Lisbon conversations ranged from the current landscape in prenatal diagnostics to the future vision of the technology and the regulatory environment that will enable it.
May 21, 2014
-
At AstraZeneca, Occasion for Introspection
Bio-IT World | On Friday, a frank assessment of AstraZeneca's R&D practices appeared in Nature Reviews Drug Discovery, just as Pfizer's repeated takeover bids have increased scrutiny of AstraZeneca's drug development pipeline.
May 19, 2014
-
LifeMap Solutions Joins New Wave of Genetic Health Companies
Bio-IT World | With a close partnership with Eric Schadt’s Icahn Institute for Genomics at Mt. Sinai, LifeMap Solutions is an intriguing – though closely-guarded – entrant into the renewed rush to provide genetic health information to patients.
May 19, 2014


